Stock EMBC EMBECTA CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Embecta Corp.

Equities

EMBC

US29082K1051

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-24 pm EDT 		5-day change 1st Jan Change
13.13 USD +2.26% Intraday chart for Embecta Corp. -9.13% -30.64%
May. 16 Transcript : Embecta Corp. Presents at Bank of America Health Care Conference 2024, May-16-2024 10:00 AM
May. 09 Health Care Climbs as Obesity-Drug Optimism Returns - Health Care Roundup DJ

Valuation

Fiscal Period: September 2022 2023 2024 2025 2026
Capitalization 1 1,665 862.4 749.1 - -
Enterprise Value (EV) 1 2,978 2,139 1,986 1,862 1,739
P/E ratio 7.4 x 12.3 x 10.8 x 7.93 x 7.44 x
Yield 0.52% 3.99% 4.36% 4.28% 4.27%
Capitalization / Revenue 1.47 x 0.77 x 0.67 x 0.67 x 0.66 x
EV / Revenue 2.64 x 1.91 x 1.78 x 1.66 x 1.54 x
EV / EBITDA 6.48 x 5.65 x 5.83 x 5.61 x 5.22 x
EV / FCF - - - - -
FCF Yield - - - - -
Price to Book -1.84 x -1.06 x -1.06 x -1.31 x -1.76 x
Nbr of stocks (in thousands) 57,836 57,304 57,670 - -
Reference price 2 28.79 15.05 13.13 13.13 13.13
Announcement Date 12/20/22 11/21/23 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: September 2021 2022 2023 2024 2025 2026
Net sales 1 1,165 1,130 1,121 1,115 1,119 1,132
EBITDA 1 - 459.9 378.7 340.6 331.9 333.1
EBIT 1 - 309.6 221.5 285.3 275.5 275.6
Operating Margin - 27.41% 19.76% 25.58% 24.62% 24.34%
Earnings before Tax (EBT) 1 - 256.6 105.7 167.6 171.5 -
Net income 1 415 223.6 70.4 70.8 98 105.8
Net margin 35.62% 19.8% 6.28% 6.35% 8.76% 9.34%
EPS 2 - 3.890 1.220 1.215 1.655 1.765
Free Cash Flow - - - - - -
FCF margin - - - - - -
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share 2 - 0.1500 0.6000 0.5718 0.5617 0.5600
Announcement Date 12/21/21 12/20/22 11/21/23 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: September 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 Q3
Net sales 1 291.1 274.6 275.7 277.1 286.1 281.9 277.3 287.2 267.6 281.7 277.5 280.5 281.7
EBITDA 1 117.9 87.2 110.2 96.7 92.2 79.6 90.4 90.8 77.9 84.95 86.3 87.94 85
EBIT 1 97.1 -3 101.6 84.9 51.3 25.8 77.5 74.9 63.07 68.65 67.83 69.02 67.3
Operating Margin 33.36% -1.09% 36.85% 30.64% 17.93% 9.15% 27.95% 26.08% 23.57% 24.37% 24.44% 24.6% 23.89%
Earnings before Tax (EBT) - -27.5 56.1 24.5 20.1 5 14.3 - - - 43 42 -
Net income 1 62.4 -17.2 35.2 14 15.2 6 20.1 28.9 8 13.8 22.55 23.1 23.4
Net margin 21.44% -6.26% 12.77% 5.05% 5.31% 2.13% 7.25% 10.06% 2.99% 4.9% 8.13% 8.23% 8.31%
EPS 2 1.070 -0.3000 0.6100 0.2400 0.2600 0.1000 0.3500 0.5000 0.1400 0.2350 0.3800 0.3900 0.4000
Dividend per Share 2 - - - - 0.1500 0.1500 0.1500 - 0.1500 0.1500 0.1500 0.1500 0.1500
Announcement Date 8/15/22 12/20/22 2/14/23 5/12/23 8/8/23 11/21/23 2/9/24 5/9/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: September 2021 2022 2023 2024 2025 2026
Net Debt 1 - 1,313 1,277 1,237 1,113 990
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) - 2.855 x 3.372 x 3.632 x 3.354 x 2.972 x
Free Cash Flow - - - - - -
ROE (net income / shareholders' equity) - - - - - -
ROA (Net income/ Total Assets) - - - - - -
Assets 1 - - - - - -
Book Value Per Share 2 - -15.60 -14.20 -12.40 -10.00 -7.470
Cash Flow per Share 2 - 7.170 1.170 0.4800 3.270 -
Capex - - - - - -
Capex / Sales - - - - - -
Announcement Date 12/21/21 12/20/22 11/21/23 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Embecta Corp.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
4
Last Close Price
12.99 USD
Average target price
15 USD
Spread / Average Target
+15.47%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
EMBECTA CORP. Stock Embecta Corp.
-30.64% 749M
ABBOTT LABORATORIES Stock Abbott Laboratories
-5.56% 181B
MEDTRONIC PLC Stock Medtronic plc
-0.11% 108B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-6.17% 66.57B
DEXCOM, INC. Stock DexCom, Inc.
+2.64% 49.95B
CENCORA, INC. Stock Cencora, Inc.
+6.58% 43.84B
HOYA CORPORATION Stock Hoya Corporation
+4.91% 41.71B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+21.98% 31.59B
TERUMO CORPORATION Stock Terumo Corporation
+14.45% 25.3B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
-5.81% 23.94B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. EMBC Stock
  4. Financials Embecta Corp.